Leslie Teso-Lichtman - Jun 27, 2022 Form 4 Insider Report for CHEMBIO DIAGNOSTICS, INC. (CEMI)

Role
Director
Signature
/s/ Mark L. Johnson, Attorney-in-Fact for Leslie Teso-Lichtman
Stock symbol
CEMI
Transactions as of
Jun 27, 2022
Transactions value $
$0
Form type
4
Date filed
6/29/2022, 05:00 PM
Previous filing
May 26, 2022
Next filing
May 1, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CEMI Restricted stock units Award $0 +64K $0.00 64K Jun 27, 2022 Common stock 64K Direct F1, F2, F3
transaction CEMI Nonqualified stock options Award $0 +82.3K $0.00 82.3K Jun 27, 2022 Common stock 82.3K $1.25 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Awards were granted in connection with the initial election of the reporting person to the board of directors of the issuer, which occurred at the issuer's 2022 annual meeting of stockholders on May 24, 2022. The grants of the awards were deferred until a sufficient number of reserved shares of common stock had become available for grant under the 2019 Omnibus Incentive Plan of the issuer.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.
F3 The restricted stock units are scheduled to vest in three equal installments immediately prior to the 2023, 2024 and 2025 annual meetings of stockholders of the issuer, or shall vest in full upon a Change in Control (as defined in the 2019 Omnibus Incentive Plan of the issuer).
F4 The nonqualified stock options are scheduled to vest and become exercisable in full immediately prior to the earlier to occur of (i) the 2023 annual meeting of stockholders of the issuer and (ii) a Change in Control.